American CryoStem Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRYO research report →
Price Chart
About the company
American CryoStem Corporation (ACSC) specializes in the development, commercialization, and licensing of technologies derived from adipose (fat) tissue, primarily for applications within regenerative and personalized medicine. Among its key offerings is the CELLECT system, designed to streamline tissue sample collection, transportation, and storage for medical practitioners. The company also provides the ATGRAFT service, a comprehensive solution for harvesting, processing, and preserving adipose tissue, enabling physicians to offer patients versatile options for tissue products and cellular banking.
- CEO
- John S. Arnone
- IPO
- 2010
- Employees
- 4
- HQ
- Eatontown, NJ, US
Get TickerSpark's AI analysis on CRYO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.43K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.22
- P/B
- -0.00
- EV/EBITDA
- -0.53
- Div Yield
- 0.00%
- Gross Margin
- 34.08%
- Op Margin
- -10710.56%
- Net Margin
- -13985.36%
- ROE
- 253.85%
- ROIC
- -817.61%
Latest fiscal year · YoY change
- Revenue
- $20.59K-96.3%
- Gross Profit
- $7.02K-98.6%
- Op Income
- $-2,205,305
- Net Income
- $-2,879,586-144.2%
- EPS
- $-0.05-149.5%
- OCF Growth
- +40.9%
- FCF Growth
- +25.1%
- 52W High
- $0.17
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 11.42
- RSI (14)
- 48
- Avg Volume
- 3.57K
No earnings-call transcripts are available for CRYO yet.
- Free Float
- 47.8%
- Shares Outstanding
- 44.28M
- Float Shares
- 21.15M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 4, 12 | ARNONE JOHN S | other | 800,000 |
| Sep 4, 12 | Dudzinski Anthony Francis | other | 580,000 |
| Apr 21, 11 | ARNONE JOHN S | other | 0 |
| Apr 21, 11 | Dudzinski Anthony Francis | other | 0 |
| Apr 21, 11 | Neill Christopher Joseph | other | 0 |
| Apr 21, 11 | ACS Global, Inc. | other | 0 |
| Apr 21, 11 | ACS Global, Inc. | other | 0 |
| Apr 23, 10 | Medina Hector | other | 0 |
| May 28, 08 | William Blair Capital Management VII, LLC | sell | 6,451 |
| May 28, 08 | William Blair Capital Management VII, LLC | other | 1,944,961 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CRYO coverage
Recent articles, reports, and earnings notes.
No research on CRYO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRYO report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.